Over the years, the Evening of Hope annual event in Washington DC, which is hosted by Patient Services Incorporated, has provided the pioneering health care charity a unique opportunity to honor various patient champions within the chronically-ill community.
At the 2016 event, PSI awarded their Patient Champion Award to Barbara Staunton Chang for her lifetime of work on behalf of chronically-ill patients around the globe.
What Is The Patient Champion Award?
The Patient Champion Award is given to a community leader whose selflessness and dedication to patient’s best represents the values and importance of personal care. In 2016 this award was presented to Barbara Chang for her tireless efforts to ensure that the bleeding disorders community have access to educational and financial support in order to maintain quality of life and care.
Who Is Barbara Staunton Chang?
Taken from our Evening of Hope 2016 notes, here’s a glimpse into Patient Champion Award recipient, Barbara Staunton Chang.
Born in Elizabeth, NJ, Barbara earned her BS at Newark campus of Rutgers University; and achieved certification as a Medical Technologist. She worked at several NJ hospitals as Blood Bank Specialist and then at age 25 became Chief Technologist.
Hired by Becton-Dickinson, Barbara was moved to Southern California where she worked 14 years in a variety of positions including being one of the first female sales representatives, product manager for a hepatitis diagnostic test then worldwide sales and marketing of blood bank reagents.
While working toward her Masters Degree in Business Administration from Central Michigan University, she met her husband Billy Chang. They have one married son, Bradford who works for Orion Healthcare.
She was wooed away from B-D by the Hyland Division of Baxter to continue her networking in International Marketing. She became product manager for Hemofil, a lyophilized factor FVIII product. After experiencing a terrible era of viral contamination with the HIV/AIDS virus, the product was re-engineered and renamed to Recombinate. Her husband Billy also worked at Baxter for a few years and worked closely on the IGIV product called Gammagard.
In speaking with Barbara about her lifetime of work, she recalled these 5 greatest moments from her time at Baxter:
- Leading the team responsible for the introduction of Home Care Therapy for various rare chronic disorders, especially hemophilia.
- Introducing better quality care for bleeding disorders in many countries, especially Japan
- Volunteering for her local hemophilia chapter, and serving as president of Hemophilia Federation of America.
- Interaction with many burgeoning non-profit organizations such as PSI, Guillain-Barre Syndrome, Immune Deficiency Foundation, Jeffrey Modell Foundation and the Hereditary angioedema, Laurie Kelley Communications.
Barbara retired from Baxter after 15 years. She re-joined the workforce in 2007 when she resumed her career with home care for chronic disorders. Barbara served the community as Director of Marketing for NCHS. Throughout the years, she always maintained her voluntary work with patients, families, chapters, government affairs, legislative advocacy and international development.
What Is The Evening Of Hope?
The Evening of Hope acknowledges, celebrates and honors patient champions in the chronically-ill community. Guests who attend can expect an extraordinary night with delicious food that reflects the fall season, cocktail hour, an exemplary company, education, and entertainment.
Highlights of the evening usually include a seated dinner, an awards ceremony, respected guest speakers, recognition of event sponsors, educational updates provided by the PSI Leadership and Government Relations teams, and live patient testimonies.
Honoring Previous Evening Of Hope Award Recipients
Every week leading up to the 2018 Evening of Hope, PSI is looking back at previous award recipients. You read our previous post here.
Tickets Are Now Available For The 2018 Evening Of Hope
Plan to attend the upcoming fifth annual Evening of Hope at The Newseum in Washington DC on September 19, 2018. Learn more here.